LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 110 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39 | -52.4% | 35,714 | 0.0% | 0.02% | -46.9% |
| Q2 2023 | $82 | -5.7% | 35,714 | 0.0% | 0.03% | -3.0% |
| Q1 2023 | $87 | +27.9% | 35,714 | 0.0% | 0.03% | +26.9% |
| Q4 2022 | $68 | -99.9% | 35,714 | 0.0% | 0.03% | -18.8% |
| Q3 2022 | $86,000 | +30.3% | 35,714 | 0.0% | 0.03% | +10.3% |
| Q2 2022 | $66,000 | -12.0% | 35,714 | 0.0% | 0.03% | -25.6% |
| Q1 2022 | $75,000 | -46.8% | 35,714 | 0.0% | 0.04% | -39.1% |
| Q4 2021 | $141,000 | -18.0% | 35,714 | 0.0% | 0.06% | -34.7% |
| Q3 2021 | $172,000 | +4.9% | 35,714 | 0.0% | 0.10% | -22.2% |
| Q2 2021 | $164,000 | -21.9% | 35,714 | 0.0% | 0.13% | +2.4% |
| Q1 2021 | $210,000 | +72.1% | 35,714 | 0.0% | 0.12% | -6.8% |
| Q4 2020 | $122,000 | +139.2% | 35,714 | 0.0% | 0.13% | +149.1% |
| Q3 2020 | $51,000 | -28.2% | 35,714 | 0.0% | 0.05% | -80.7% |
| Q2 2020 | $71,000 | +1.4% | 35,714 | 0.0% | 0.28% | +183.5% |
| Q1 2020 | $70,000 | -52.7% | 35,714 | 0.0% | 0.10% | -38.6% |
| Q4 2019 | $148,000 | -34.2% | 35,714 | 0.0% | 0.16% | -43.4% |
| Q2 2019 | $225,000 | +13.1% | 35,714 | 0.0% | 0.28% | +10.3% |
| Q1 2019 | $199,000 | -16.0% | 35,714 | 0.0% | 0.25% | -1.2% |
| Q4 2018 | $237,000 | -37.8% | 35,714 | 0.0% | 0.26% | -45.6% |
| Q3 2018 | $381,000 | -11.2% | 35,714 | 0.0% | 0.47% | +185.5% |
| Q2 2018 | $429,000 | +40.2% | 35,714 | 0.0% | 0.16% | +36.4% |
| Q1 2018 | $306,000 | -13.3% | 35,714 | 0.0% | 0.12% | -91.1% |
| Q4 2017 | $353,000 | -19.6% | 35,714 | 0.0% | 1.36% | +29.6% |
| Q3 2017 | $439,000 | -25.2% | 35,714 | 0.0% | 1.05% | -39.7% |
| Q2 2017 | $587,000 | +14.6% | 35,714 | 0.0% | 1.74% | +30.5% |
| Q1 2017 | $512,000 | +3.6% | 35,714 | 0.0% | 1.34% | -5.6% |
| Q4 2016 | $494,000 | -23.4% | 35,714 | 0.0% | 1.42% | -17.6% |
| Q3 2016 | $645,000 | +26.0% | 35,714 | 0.0% | 1.72% | +15.6% |
| Q2 2016 | $512,000 | +19.9% | 35,714 | 0.0% | 1.49% | +11.7% |
| Q1 2016 | $427,000 | -10.1% | 35,714 | 0.0% | 1.33% | +36.2% |
| Q4 2015 | $475,000 | +23.7% | 35,714 | 0.0% | 0.98% | +416.9% |
| Q3 2015 | $384,000 | +33.8% | 35,714 | 0.0% | 0.19% | +83.5% |
| Q2 2015 | $287,000 | – | 35,714 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |